Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: How DL views himself

44. Second, the proposed salary deferrals by Daniel Leckrone, Susan Anhalt and Janet Neal are minor in light of their exorbitant salaries of $480,000, $250,000 and $247,000 respectively.

[November Disclosure Statement, Ex. C]. Such salaries are especially dumbfounding when considered in light of the fact that TPL is essentially a holding company8 and that the officers’ duties and roles remain unclear……

­­­­­­__________

8 The November Disclosure Statement describes the Debtor as “a managerial and litigation support entity.” [November Disclosure Statement, p, 22, line 8]. Given the numerous third party counsel and litigation support professionals it employs, this begs the question of to what extent does TPL play a role in generating revenue.

Haven’t PTSC shareholders been asking for years, “to what extent does TPL play a role in generating revenue.” Come on Cliff, Carl, Gloria....make a power play now.

Share
New Message
Please login to post a reply